Inovio Pharmaceuticals (INO) Earnings Date, Estimates & Call Transcripts → This indicator is great for calling bottoms (From WealthPress) (Ad) Free INO Stock Alerts $9.71 -0.01 (-0.10%) (As of 06/11/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Earnings SummaryUpcoming Earnings DateAug. 14EstimatedActual EPS (May. 13) -$1.31 Missed By -$0.23 Consensus EPS (May. 13) -$1.08 Read Call TranscriptListen to CallLatest SEC 10-Q Filing Get Inovio Pharmaceuticals Earnings AlertsEnter your email address below to receive the latest news and earnings results for INO and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueINO Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.INO Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad TradingTipsTop 10 AI Stocks to Buy NowAre you ready to capitalize on the booming AI market? Our experts have identified the top 10 AI stocks set to skyrocket.Download our free report today Inovio Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20241($1.17)($1.17)($1.17)Q2 20241($1.28)($1.28)($1.28)Q3 20241($1.18)($1.18)($1.18)Q4 20241($1.14)($1.14)($1.14)FY 20244($4.77)($4.77)($4.77)Q1 20251($1.16)($1.16)($1.16)Q2 20251($1.07)($1.07)($1.07)Q3 20251($0.99)($0.99)($0.99)Q4 20251$1.20$1.20$1.20FY 20254($2.02)($2.02)($2.02)INO Earnings Date and InformationInovio Pharmaceuticals last announced its earnings data on May 13th, 2024. The biopharmaceutical company reported ($1.31) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($1.08) by $0.23. Inovio Pharmaceuticals has generated ($3.19) earnings per share over the last year (($3.19) diluted earnings per share). Earnings for Inovio Pharmaceuticals are expected to grow in the coming year, from ($4.50) to ($3.16) per share. Inovio Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 14th, 2024 based off prior year's report dates.Read More Inovio Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/14/2024(Estimated)------- 5/13/2024Q1 2024($1.08)($1.31)($0.23)($1.31)$0.23 million- 11/9/2023Q3 2023($18.72)($12.96)+$5.76($0.05)$0.18 million$0.39 million8/9/2023Q2 2023($20.16)($18.72)+$1.44($0.13)$0.20 million$0.23 million 5/10/2023Q1 2023($20.16)($23.04)($2.88)($0.16)$0.20 million$0.11 million 3/1/2023Q4 2022($23.04)($31.68)($8.64)($0.21)$0.46 million$0.13 million 11/8/2022Q3 2022($41.76)($21.60)+$20.16($0.15)$0.53 million$9.15 million Get the Latest News and Ratings for INO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Inovio Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 8/9/2022Q2 2022($43.20)($66.24)($23.04)($0.46)$0.52 million$0.78 million 5/10/2022Q1 2022($40.32)($51.84)($11.52)($0.36)$0.66 million$0.20 million 3/1/2022Q4 2021($47.52)($72.00)($24.48)($0.50)$0.55 million$0.84 million 11/9/2021Q3 2021($47.52)($41.76)+$5.76($0.29)$0.19 million$0.29 million 8/9/2021Q2 2021($36.00)($56.16)($20.16)($0.39)$1.21 million$0.27 million 5/10/2021Q1 2021($25.92)($38.88)($12.96)($0.27)$1.06 million$0.40 million 2/28/2021Q4 2020($31.68)($20.16)+$11.52($0.14)$1.22 million$5.60 million 11/9/2020Q3 2020($27.36)$15.84+$43.20($0.55)$3.05 million$0.24 million 8/10/2020Q2 2020($24.48)($119.52)($95.04)($0.37)$2.61 million$0.20 million 5/11/2020Q1 2020($31.68)($37.44)($5.76)($0.26)$1.55 million$1.33 million 3/12/2020Q4 2019($34.56)($54.72)($20.16)($0.26)$1.36 million$0.28 million 11/12/2019Q3 2019($37.44)($36.00)+$1.44($0.29)$2.72 million$0.87 million 8/8/2019Q2 2019($40.32)($43.20)($2.88)($0.30)$4.69 million$0.14 million Inovio Pharmaceuticals Earnings - Frequently Asked Questions When is Inovio Pharmaceuticals's earnings date? Inovio Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 14th, 2024 based off last year's report dates. Learn more on INO's earnings history. Did Inovio Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Inovio Pharmaceuticals (NASDAQ:INO) missed the analysts' consensus estimate of ($1.08) by $0.23 with a reported earnings per share (EPS) of ($1.31). Learn more on analysts' earnings estimate vs. INO's actual earnings. How can I listen to Inovio Pharmaceuticals's earnings conference call? The conference call for Inovio Pharmaceuticals's latest earnings report can be listened to online. Listen to Conference Call How can I read Inovio Pharmaceuticals's conference call transcript? The conference call transcript for Inovio Pharmaceuticals's latest earnings report can be read online. Read Transcript How can I view Inovio Pharmaceuticals's earnings report? Inovio Pharmaceuticals's earnings report can be found in their filing with the SEC. View SEC filing How much revenue does Inovio Pharmaceuticals generate each year? Inovio Pharmaceuticals (NASDAQ:INO) has a recorded annual revenue of $830,000.00. How much profit does Inovio Pharmaceuticals generate each year? Inovio Pharmaceuticals (NASDAQ:INO) has a recorded net income of -$135.12 million. INO has generated -$3.19 earnings per share over the last four quarters. What is Inovio Pharmaceuticals's EPS forecast for next year? Inovio Pharmaceuticals's earnings are expected to grow from ($4.50) per share to ($3.16) per share in the next year. More Earnings Resources from MarketBeat Related Companies: AORT Earnings CATX Earnings SILK Earnings ATRI Earnings PLSE Earnings KIDS Earnings EMBC Earnings SRDX Earnings FNA Earnings SIBN Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: CrowdStrike's Earnings: Consolidation and AI-Driven Growth The Most Upgraded Stocks After the Q1 Earnings Season ZIM Shipping Stock Forecast, Earnings Triggers a BuyAmerican Superconductor's Earnings Surge, Future Growth ExpectedHormel: A Potential Buy Despite Post-Earnings DeclineCanopy Growth’s Earnings: Profitability Despite Industry ShiftsAbercrombie & Fitch First Quarter Earnings Surge to New Heights This page (NASDAQ:INO) was last updated on 6/11/2024 by MarketBeat.com Staff From Our PartnersBiden Nomination CANCELED?And I believe when they do take the oath of office, their fingers will be crossed… and America will descend in...The Freeport Society | SponsoredNVDA to close the AI “wealth window’ June 25?On Tuesday, June 25, in front of executives from nearly every major tech company in existence, key leaders at ...Paradigm Direct | Sponsored"If I Die, I’d Trust 50% of My Daughters’ Inheritance in ONE Stock.""I'd Feel Secure Putting 50% of My Kids' Inheritance in THIS Stock" One Wall Street millionaire bought AAPL...Stansberry Research | SponsoredDON’T buy gold until you read thisIf you're an American who understands that your money is rotting away as you read this email… Then this is ...Sasco Gold LLC | SponsoredGold Set to EXPLODE!The perfect storm is brewing to drive gold's price through the roof! And our weakening dollars are causing ...Gold Safe Exchange | SponsoredShocking $16T Elon Musk Crypto LeakReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto mark...Crypto 101 Media | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inovio Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Inovio Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.